Carcass cutting yields and meat quality of market gilts managed with immunological suppression of ovarian function and estrus.

The objective of this study was to analyze the effects of immunological suppression of ovarian function and estrus (Improvest®; Zoetis Inc.) on carcass cutting yields and meat quality. A total of 1,080 gilts were allocated by weight and assigned to pens of 27 pigs/pen.

Use of quantitative mass spectrometry-based proteomics and ELISA to compare the alpha 2 macroglobulin concentration in equine blood-based products processed by three different orthobiologic devices.

Introduction: Alpha 2 macroglobulin (A2M), a multi-functional protein in the plasma protease inhibitor class, regulates proinflammatory cytokines and the clearance of chondrodestructive enzymes in cases of joint injury and osteoarthritis (OA). The purpose of this study was to compare A2M concentrations in equine plasma samples processed by three commercial devices developed for stall-side regenerative joint therapy.

Methods: Plasma samples were obtained from healthy adult horses ( = 13).

Evaluation of Improvest effects on production parameters of gilts from two different genetic sire lines.

The objective was to evaluate the effects of Improvest on the performance and carcass characteristics of gilts from two different genetic sire lines and the performance of Improvest gilts with castrated male pigs. It was hypothesized that performance parameters observed for Improvest gilts would be similar to barrows, thus narrowing the performance gaps between traditionally managed gilts and barrows. Pigs were from Large White/Landrace dams and either Duroc-Pietrain () or Duroc () sires.

The effect of timing of Improvest administration on growth performance and carcass characteristics in gilts.

Improvest (; Zoetis Inc., Parsippany, NJ) has been approved by the U.S.

Diminished antimicrobial drug use in dogs with allergic dermatitis treated with oclacitinib.

Introduction: Dogs with allergic dermatitis often suffer concurrent skin and ear infections. The objective of this study was to retrospectively quantify the number of systemic and topical antimicrobial transactions in dogs with allergic dermatitis, following administration of oclacitinib or a glucocorticoid, compared to dogs that did not receive a pruritus therapy when there is an initial diagnosis of pyoderma. A secondary objective was to demonstrate that dogs on oclacitinib use fewer antimicrobials and concomitant therapies over time and have improved quality of life.